WebApr 11, 2024 · Blackstone Inc. (NYSE:BX)’s beta value is currently sitting at 1.49, while the Average True Range indicator is currently displaying 3.16. With analysts defining $69.00-$115.00 as the low and high price targets, we arrive at a consensus price target of $99.18 for the trailing 12-month period. The current price is about 16.82% off the estimated ... WebFind the latest Blackstone Inc. (BX) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest Blackstone Inc. (BX) stock discussion in Yahoo Finance's forum. … See the company profile for Blackstone Inc. (BX) including business summary, … At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio … Discover historical prices for BX stock on Yahoo Finance. View daily, weekly or … The latest news and headlines from Yahoo! News. Get breaking news stories and in … Find the latest Blackstone Inc. (BX) stock quote, history, news and other vital … See Blackstone Inc. (BX) Environment, Social and Governance Ratings to help … Holder Shares Date Reported % Out Value; Vanguard Total Stock Market Index Fund: … See Blackstone Inc. (BX) stock analyst estimates, including earnings and …
Blackstone Inc. (BX) Stock Price, Quote & News - Stock Analysis
WebApr 13, 2024 · About Blackstone (NYSE:BX) Stock Blackstone, Inc. engages in the provision of investment and fund management services. It operates through the following segments: Real Estate, Private Equity, Credit and Insurance, and Hedge Fund Solutions. WebApr 13, 2024 · Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Blackstone Inc. … fangirl bedroom backgrounds
Blackstone Inc (BX) Stock Price & News - Google Finance
WebApr 4, 2024 · Company Profile BX Business Description Blackstone is one of the world's largest alternative asset managers with $950.9 billion in total asset under management, including $705.9 billion in... WebInhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan … WebIn certain circumstances, securities with respect to which the relevant exchange has commenced delisting proceedings may continue to be traded pending appeal of that determination. To view a list of securities that are subject to delisting, including those that continue to be traded pending appeal, please click here. corn bread stuffing for fish